Systematic ReviewTreatment: Trigger Point InjectionSystematic Reviews & Meta-analysesClinical RelevanceDOI
3 min read
Jump to:

Patient-friendly summary

If you read nothing else

This review shows botulinum toxin helps with pain in many conditions, like stroke and muscle stiffness.

Bottom line

Botulinum toxin shows promise in treating pain across various conditions and is worth discussing with your provider.

Moderate evidence

Published

2024
2 years ago
Current

Evidence hierarchy

Meta-analysis
Systematic Review ◀ this study
RCT
Cohort
Case-Control
Case Report
Expert Opinion

Study participants

33 studiesnot specifiednot specified

various painful syndromes including stroke/brain injury and epicondylitis

Words decoded

Botulinum toxin
— A protein that can help relax muscles and is used to treat pain and spasticity.
Spasticity
— Stiffness and tightness in muscles, often seen after a stroke or brain injury.
Rehabilitation
— The process of helping people recover and adapt to life after an illness or injury.
Full research — for clinicians and curious readers

Study Summary

Background

Botulinum toxin (BTX) has emerged as a promising treatment for various painful conditions, working through multiple mechanisms including muscle relaxation and direct modulation of pain pathways. Pain significantly impacts rehabilitation outcomes and quality of life across many conditions. This study provides a comprehensive analysis of the current evidence for BTX in pain management using multiple analytical approaches.

What They Did

The researchers searched PubMed for papers published in the last 10 years about botulinum toxin, pain, and rehabilitation. They analyzed 189 papers using three different approaches: a multiperspective analysis examining publication trends and characteristics; a lexical analysis using graph theory to identify common words and their relationships; and a systematic review of 33 randomized controlled trials (RCTs) evaluating BTX effectiveness for pain.

What They Found

The review identified that most research comes from rehabilitation and neurology departments, with stroke/brain injury and epicondylitis being the most studied conditions. The lexical analysis revealed "pain" as the most frequent term (34% of papers), followed by "treatment" (16%). Among the 33 RCTs analyzed, 22 studies showed BTX was more effective than control treatments for pain reduction. The most commonly used outcome measures were pain scales (55% used visual analog scale), function assessments, and spasticity measures.

BTX was typically injected into muscles (24 studies) or joints (4 studies), with various BTX formulations used. The overall risk of bias was low to moderate across studies.

What This Means

This comprehensive analysis supports the use of botulinum toxin for pain management in rehabilitation settings. The evidence shows BTX is effective for various painful conditions through both muscle relaxation and direct pain pathway modulation. However, the authors note limitations in current research including limited outcome measures beyond pain and function, lack of standardized approaches across conditions, and insufficient global research representation. Future studies should include more comprehensive assessments including imaging and biopsychosocial factors to better understand BTX's mechanisms and optimize treatment protocols.

80/100
Evidence StrengthStrong
Study Quality
Sample Size
Replication
189
Total Studies Analyzed
22/33
RCTs Showing BTX Superiority
34%
Papers Mentioning Pain
42%
Studies from Rehabilitation Departments

Key Findings

22 out of 33 RCTs showed BTX superior to control for pain reliefHigh

Majority of high-quality randomized trials demonstrated BTX effectiveness across multiple painful conditions

Stroke/brain injury and epicondylitis most studied conditionsMedium

These conditions had the highest representation in rehabilitation and neurology literature

Pain was the most frequent term in 34% of papersMedium

Lexical analysis revealed strong focus on pain outcomes in BTX research

Low to moderate risk of bias across RCTsHigh

Most studies showed good methodological quality with proper randomization and blinding

Multiple BTX mechanisms support pain reliefHigh

Evidence supports both muscle relaxation and direct sensory pathway modulation

Study Methodology
Study Design
Multiperspective literature analysis with systematic review component
Sample Size
189 total papers, 33 RCTs for systematic review
Duration
10-year literature search period
Population
Various painful conditions including stroke, epicondylitis, cerebral palsy, osteoarthritis
Outcome Measures
Pain scales · Function assessments · Spasticity measures · Quality of life questionnaires

Strengths

  • Comprehensive analysis using multiple analytical approaches
  • Large number of studies included (189 papers)
  • Systematic methodology with proper bias assessment
  • Novel lexical analysis provides unique insights into research trends

Limitations

  • Limited to English-language publications primarily
  • Grouping of diverse conditions may obscure specific effects
  • Lack of standardized outcome measures across studies
  • Limited global representation with bias toward developed countries

Key Takeaways for Patients

What This Means for You

  1. 01Botulinum toxin is an effective treatment for pain in many conditions beyond cosmetic uses
  2. 02The treatment works through multiple mechanisms including muscle relaxation and direct pain relief
  3. 03Most research shows botulinum toxin provides better pain relief than placebo or other treatments
  4. 04Evidence is strongest for stroke-related pain and tennis elbow, but benefits extend to other conditions
  5. 05Treatment involves injections into muscles or joints, typically with few side effects

Read the Full Paper

Access the complete peer-reviewed study from European Journal of Translational Myology

View Full Study

Related Research

●●●●● LandmarkSystematic Review

Effectiveness of Percutaneous Needle Electrolysis (PNE) and Intramuscular Electrical Stimulation (IMES) in the Management of Myofascial Pain Syndrome and Tendinopathies: A Systematic Review

Trybulski et al.·Journal of Clinical Medicine·2026

This systematic review found that PNE and IMES may improve pain and function in myofascial pain syndrome and tendinopathies, but evidence quality was limited by high risk of bias. Both techniques appear safe with only minor, self-limiting adverse events.

Systematic Reviews & Meta-analysesRead →
●●●●● LandmarkSystematic Review

Dry Needling in Sports and Sport Recovery: A Systematic Review with an Evidence Gap Map

Kużdżał et al.·Sports Medicine·2025

This systematic review of 24 studies found dry needling effectively reduces pain in injured athletes but shows mixed results for performance enhancement in healthy athletes. Significant research gaps exist for elite athletes and long-term effects.

Systematic Reviews & Meta-analysesRead →
●●●●● LandmarkMeta-analysis

Comparative effectiveness of noninvasive therapeutic interventions for myofascial pain syndrome: a network meta-analysis of randomized controlled trials

Liu et al.·International Journal of Surgery·2024

Network meta-analysis of 40 RCTs found manual therapy, laser therapy, and extracorporeal shock wave therapy most effective for reducing pain and disability in myofascial pain syndrome. These three treatments showed benefits across pain intensity, pressure pain threshold, and functional outcomes comp

Systematic Reviews & Meta-analysesRead →
●●●●● LandmarkSystematic Review

Clinical Effectiveness of Dry Needling in Patients with Musculoskeletal Pain—An Umbrella Review

Chys et al.·Journal of Clinical Medicine·2023

This umbrella review of 36 systematic reviews found strong evidence that dry needling provides superior short-term pain reduction compared to sham treatments across all body regions. DN is equally effective to other treatments and may provide additional benefit when combined with conventional physio

Systematic Reviews & Meta-analysesRead →